CD8A and nonpapillary renal cell carcinoma: Clark et al. demonstrated across a range of ccRCC tumor stages, from localized to metastatic, tumors classified as CD8+ inflamed, were associated with worse overall survival and other poor prognostic features, including higher BAP1 mutations, higher grade tumors and increased PD-1/PD-L1 expression [65].